Mechanistically, pharmacological degradation of GSPT1 leads toimpaired translation termination, activation of the integrated stress responsepathway, and TP53-independent cell death in AML cells, with minimal effect on normalhematopoietic stem cells (56). The gene discussed is TP53; the disease is acute myeloid leukemia.